Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

USC Eye Institute Adds 12 Faculty Physician Scientists in 2014
  • USA - English


News provided by

Goldman Marketing Group

Dec 18, 2014, 06:00 ET

Share this article

Share toX

Share this article

Share toX

Youtube
Youtube

Los Angeles, CA (PRWEB) December 18, 2014 -- The University of Southern California (USC) Eye Institute has recruited 12 physician scientists from some of the world’s leading institutions, specializing in the diagnosis and treatment of a wide spectrum of vision disorders.

“I am extremely pleased to welcome the new faculty hires, and it is my privilege to lead this extraordinary group going forward.” - Rohit Varma, M.D., M.P.H., director of the USC Eye Institute and professor and chair of ophthalmology at the Keck School.

Post this

The recruitment is part of an overarching growth strategy that anticipates increased demand in eye care services. According to the National Eye Institute, more than 65 percent of Americans 40 years or older suffer from some sort of vision impairment – ranging from near- or far-sightedness to blindness. That number is expected to swell as the population ages.

Each physician recruit contributes expertise in a unique area of specialization, expanding the depth and breadth of services offered at the USC Eye Institute in ocular oncology, glaucoma, orbit and oculo-facial reconstructive surgery, cornea and external diseases, refractive surgery, neuro-ophthalmology, pediatric ophthalmology, adult strabismus and retinal diseases.

Most of the new physicians also boast a multi-cultural pedigree.

“Los Angeles patients represent a diverse, multicultural population and require more than a ‘one-size-fits-all’ health care approach,” said Tom Jackiewicz, senior vice president and CEO of USC Health. “At Keck Medicine of USC, we take a more personalized patient-centered approach. We welcome patients from all backgrounds, and we are proud to hire specialists who mirror that diversity.”

The institute’s new hires include Hossein Ameri, M.D. (retinal diseases and degeneration); Jesse L. Berry, M.D. (ocular oncology); Charles W. Flowers, Jr., M.D. (cornea, cataract and refractive surgery); Veronica L. Isozaki, O.D. (complex contact lens care); Andrew A. Moshfeghi, M.D., MBA (retinal diseases); Arlanna Moshfeghi, M.D., M.P.H. (pediatric ophthalmology); Vivek R. Patel, M.D. (neuro-ophthalmology and adult strabismus); Alena Reznik, M.D. (glaucoma); Grace Richter, M.D., M.P.H. (glaucoma); Damien C. Rodger, M.D. (retinal diseases and uveitis); Jonathan Song, M.D. (corneal disease, cataract and refractive surgery) and Sandy X. Zhang-Nunes, M.D. (oculo-facial plastic surgery). Andrew and Arlanna Moshfeghi, Richter and Rodger are scheduled to begin seeing patients in 2015.

The Department of Ophthalmology at the Keck School of Medicine of USC began seeing patients in 1974. As the cornerstone of the department, the USC Eye Institute celebrates its 40th anniversary in June 2015 as an internationally recognized center of excellence in vision research, clinical care and education.

“The USC Eye Institute is pioneering the development of novel treatments for eye diseases that cause vision loss and contributing critical scientific knowledge to advance the field of ophthalmology,” said Carmen A. Puliafito, M.D., MBA, dean of the Keck School and professor of ophthalmology. “This can only be done successfully by organizations like USC that emphasize the importance of integrating research, patient care and education.”

Over the past four decades, USC Eye Institute faculty members have received international acclaim for their contributions to vision research and patient care, including the development of optical coherence tomography, a non-invasive imaging technique used to diagnose glaucoma and retinal disorders, and the Baerveldt glaucoma implant, the world’s most widely used glaucoma implant. USC Eye Institute physician scientists developed the only commercially available retinal prosthesis to restore vision to those blind from retinitis pigmentosa and a long-term ocular drug delivery pump for the treatment of diabetic eye disease and macular degeneration. The USC Eye Institute also is one of the leading eye centers in the world studying the burden of vision loss and its impact on quality of life among vulnerable populations such as children and minorities.

“I am extremely pleased to welcome the new faculty hires, and it is my privilege to lead this extraordinary group going forward,” said Rohit Varma, M.D., M.P.H., director of the USC Eye Institute and professor and chair of ophthalmology at the Keck School of Medicine. “We hope to bring several more talented academic physicians on board within the next year, but I believe we are well-positioned to build on all of our strengths and continue to innovate, develop and fulfill our collective mission of providing the highest quality of patient-centered care.”

About USC Eye Institute
The USC Eye Institute, part of Keck Medicine of USC, is led by Rohit Varma, M.D., M.P.H., and has more than 20 full-time faculty physicians covering all subspecialties of ophthalmology. USC's ophthalmology program has been ranked in the Top 10 by U.S. News & World Report for 20 years and is No. 3 in research funding from the National Eye Institute. The USC Eye Institute is headquartered near downtown Los Angeles and has satellite clinics in Pasadena, Beverly Hills and Arcadia. For more information, go to http://www.eye.keckmedicine.org/.

About Keck Medicine of USC
Keck Medicine of USC is the University of Southern California's medical enterprise, one of only two university-based medical systems in the Los Angeles area. Encompassing academic, research and clinical excellence, the medical system attracts internationally renowned experts who teach and practice at the Keck School of Medicine of USC, the region’s first medical school; includes the renowned USC Norris Comprehensive Cancer Center, one of the first comprehensive cancer centers established by the National Institutes of Health (NIH) in the United States; has a medical faculty practice, the USC Care Medical Group; operates the Keck Medical Center of USC, which includes two acute care hospitals: 401-licensed bed Keck Hospital of USC and 60-licensed bed USC Norris Cancer Hospital; and owns USC Verdugo Hills Hospital, a 158-licensed bed community hospital. It also includes more than 40 outpatient facilities, some at affiliated hospitals, in Los Angeles, Orange, Kern, Tulare and Ventura counties.

U.S. News & World Report ranked Keck Medical Center of USC among the Top 10 in ophthalmology (No. 9), and among the Top 25 hospitals in the United States for urology (No. 20) and cancer care (No. 23). The medical center was also awarded an “A” grade from The Leapfrog Group in 2014, representing outstanding patient safety practices and overall patient outcomes.

For more information, go to http://www.keckmedicine.org/beyond.

Risa Goldman, Goldman Marketing Group, +1 818-861-7092, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.